Release Date: 2024-06-10

Interventional Radiological Treatments in Lung Cancer

Mesut Ozgokce (Author)

Release Date: 2024-06-10

Lung cancer (LC) is the leading cause of cancer-related deaths globally, with about 1.76 million deaths in 2018. Smoking is the main risk factor, along with genetic predisposition and asbestos exposure. Primary LC starts in the lung tissue, while secondary LC spreads from other body parts to the lungs. LC is often classified into small [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inThe Radiology of Cancer
    First Page519
    Last Page527
    DOIhttps://doi.org/10.69860/nobel.9786053359364.33
    Page Count9
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Lung cancer (LC) is the leading cause of cancer-related deaths globally, with about 1.76 million deaths in 2018. Smoking is the main risk factor, along with genetic predisposition and asbestos exposure. Primary LC starts in the lung tissue, while secondary LC spreads from other body parts to the lungs. LC is often classified into small cell and non-small cell types, which affects treatment plans. For non-small cell LC, surgical removal is the first option. Advanced cases might be treated with chemotherapy, radiotherapy, or combinations, but complete remission is rare. Minimally invasive treatments like microwave ablation (MWA), radiofrequency ablation (RFA), and cryoablation are used for local tumor control, especially in patients who can't undergo surgery. These methods help preserve lung function and improve quality of life. New techniques like Cyber-knife and Gamma knife are also emerging as alternatives to traditional ablation methods.

    Mesut Ozgokce (Author)
    Professor, Van Yuzuncu Yil University
    https://orcid.org/0000-0002-3095-2446
    3He completed primary and high school education in Van. He studied at Kocaeli University Medical School. Later, he did radiology residency at Atatürk University. He completed his mandatory service as a radiology specialist at Van Training and Research Hospital for two years. Afterwards, he worked at a private hospital for one year. Since 2016, he has been working in the Radiology Department at Van Yüzüncü Yıl University, specializing in both cardiothoracic imaging and interventional radiology. He received associate professorship in 2018 and has been serving as a professor since June 2024. He has published numerous scientific articles and given oral presentations at both national and international conferences. For English language training, he spent some time in Dublin (Ireland). Later, He worked as an observer in interventional radiology at UPM University (Malaysia) and Rush University (Chicago). Additionally, he is a member of the Turkish Society of Interventional Radiology, the Turkish Radiology Society, and the Turkish Thoracic Radiology Society.

    • Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2008 Aug;3(8):819-31.

    • Organization; WH. Cancer. 2018, September 12. Available online: https://www.who.int/news-room/factsheets/detail/ cancer

    • Nitadori J, Inoue M, Iwasaki M, Otani T, Sasazuki S, Nagai K, Tsugane S. Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest. 2006 Oct;130(4):968-75.

    • Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, Abbruzzese JL. Metastatic patterns in adenocarcinoma. Cancer. 2006 Apr 1;106(7):1624-33.

    • Wright G, Manser RL, Byrnes G, Hart D, Campbell DA. Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials. Thorax. 2006 Jul;61(7):597-603

    • Prud’homme C, Deschamps F, Moulin B, et al. Imageguided lung metastasis ablation: a literature review. Int J Hyperthermia 2019;36:37-45

    • Ettinger DS, Wood DE, Aggarwal C, et al. Non-small cell lung cancer, version 1.2020: Featured updates to the NCCN guidelines. JNCCN 2019;17:1464-72

    • Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR American journal of roentgenology. 2000 Jan;174(1):579.

    • Nahum Goldberg S, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities--part I. Journal of vascular and interventional radiology : JVIR. 2001 Sep;12(9):1021-32

    • Ahmed M, Liu Z, Afzal KS, Weeks D, Lobo SM, Kruskal JB, Lenkinski RE, Goldberg SN. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology. 2004 Mar;230(3):761-7. 50

    • Gananadha S, Morris DL. Saline infusion markedly reduces impedance and improves efficacy of pulmonary radiofrequency ablation. Cardiovascular and interventional radiology. 2004 Jul-Aug;27(4):361-5.

    • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer. 2010 Dec 15;127(12):2893-917.

    • Tafti BA, Genshaft S, Suh R, et al. Lung Ablation: Indications and Techniques. Semin Intervent Radiol 2019;36:163-75

    • Lu DS, Raman SS, Vodopich DJ, et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the “heat sink” effect. AJR Am J Roentgenol 2002;178:47-51

    • Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics : a review publication of the Radiological Society of North America, Inc. 2005 Oct;25 Suppl 1:S69-83.

    • Skinner MG, Iizuka MN, Kolios MC, Sherar MD. A theoretical comparison of energy sources--microwave, ultrasound and laser--for interstitial thermal therapy. Physics in medicine and biology. 1998 Dec;43(12):3535-47.

    • Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee FT, Jr. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology. 2009 Jun;251(3):705-11.

    • Shock SA, Meredith K, Warner TF, Sampson LA, Wright AS, Winter TC, 3rd, Mahvi DM, Fine JP, Lee FT Jr. Microwave ablation with loop antenna: in vivo porcine liver model. Radiology. 2004 Apr;231(1):143-9

    • Wolf FJ, Grand DJ, Machan JT, Dipetrillo TA, Mayo-Smith WW, Dupuy DE. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008 Jun;247(3):871-9.

    • Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology. 2011 Nov;261(2):643-51

    • Yang X, Ye X, Zheng A, et al. Percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: clinical evaluation of 47 cases. J Surg Oncol. 2014;110:758–63.

    • Wei Z, Ye X, Yang X, et al. Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone. Med Oncol. 2015;32:464.

    • Xu X, Ye X, Liu G, et al. Targeted percutaneous microwave ablation at the pulmonary lesion combined with mediastinal radiotherapy with or without concurrent chemotherapy in locally advanced non-small cell lung cancer evaluation in a randomized comparison study. Med Oncol. 2015;32:227

    • Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005 Apr;235(1):289-98

    • Allaf ME, Varkarakis IM, Bhayani SB, et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation—initial observations. Radiology 2005;237:366-70.

    • Golder WA. Chemoembolization of the lungs: basic anatomical elements, experimental results, clinical experience. Onkologe. 2008;14:934–9.

    • Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583–92

    • Vogl TJ, Shafinaderi M, Zangos S, et al. Regional chemotherapy of the lung: transpulmonary chemoembolization in malignant lung tumors. Semin Intervent Radiol. 2013;30:176–84

    • Macchi M, Belfiore MP, Floridi C, et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol 2017;34:96.

    • Chi J, Ding M, Shi Y, et al. Comparison study of computed tomography-guided radiofrequency and microwave ablation for pulmonary tumors: A retrospective, case-controlled observational study. Thorac Cancer 2018;9:1241-8

    • Jiang B, Mcclure MA, Chen T, et al. Efficacy and safety of thermal ablation of lung malignancies: A Network metaanalysis. Ann Thorac Med 2018;13:243-50

    • Neu WK, Neu JC. Mechanism of irreversible electroporation in cells: Insight from the models. In: Rubinsky B. Irreversible Electroporation. Berlin: Springer, 2010:85-122

    • Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005;33:223-31.

    • Sabath BF, Casal RF. Bronchoscopic ablation of peripheral lung tumors. J Thorac Dis 2019;11:2628-38.

    • Lencioni R, Crocetti L, Cioni R, Suh R, Glenn D, Regge D, Helmberger T, Gillams AR, Frilling A, Ambrogi M, Bartolozzi C, Mussi A. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-totreat, multicentre clinical trial (the RAPTURE study). The lancet oncology. 2008 Jul;9(7):621-8.

    • Smith S, Gillams A. Imaging appearances following thermal ablation. Clinical radiology. 2008 Jan;63(1):111

    • Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR American journal of roentgenology. 2005 Aug;185(2):466-71.

    Share This Chapter!